The CTD2 Dashboard: A Platform to Explore Evidence-based Observations

The Cancer Genome Atlas (TCGA), TARGET, and other large-scale sequencing projects such as the International Cancer Genome Consortium (ICGC), have catalogued a vast number of genetic abnormalities in cancer. However, identifying these abnormalities is just one part of the puzzle.

Next, cancer researchers need to determine which changes drive cancer development, metastasis, and drug resistance, and how this information can be used to improve cancer care and early detection. The Cancer Target Discovery and Development (CTD²) Dashboard displays evidence-based conclusions on an interactive web interface for users to learn more about the biology of cancer.

from Cancer via ola Kala on Inoreader http://ift.tt/1VRQlac
via IFTTT